Premium
Comparison of hepatocellular carcinoma in E astern versus W estern populations
Author(s) -
Choo Su Pin,
Tan Wan Ling,
Goh Brian K. P.,
Tai Wai Meng,
Zhu Andrew X.
Publication year - 2016
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30237
Subject(s) - medicine , etiology , hepatocellular carcinoma , clinical trial , epidemiology , cancer , disease , oncology , demography , sociology
Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent in many Asian countries and is the second most common cause of cancer‐related mortality worldwide. Significant differences exist between Eastern and Western populations on many key aspects of HCC, contributing to the potential different treatment outcomes and challenges of clinical trial design and data interpretation. In this review, the authors compare HCC in Asia versus the West and highlight 1) differences in terms of epidemiology and trends and their correlation with etiology, 2) differences in genetics and how they relate to underlying etiology, 3) differences in treatment approaches based on existing guidelines and consensus statements, and 4) differences in clinical outcomes for Asian versus non‐Asian patients with HCC in clinical trials and the implications for future clinical trial design. Cancer 2016;122:3430–3446 . © 2016 American Cancer Society